Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

Shares of Amgen (Nasdaq: AMGN) started crashing in early November and didn’t improve when the company released data from a ...

Learn more about whether Encompass Health Corporation or Fresenius Medical Care AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

New study challenges conventional wisdom about cholesterol! High levels of 'good cholesterol' may increase the risk of ...

surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class of pain treatment approved in more than ...

A bridesmaid who agreed to take part in a destination wedding in Hawaii was left regretting her decision after being treated as an outsider. Her experience, shared by her sympathetic friend in a ...

The approach has historically led the managers to scoop up firms whose stock prices are plunging ... shifted from Miller Value Partners to Patient Capital Management, a firm McLemore established ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Donald Trump has dealt this company a big blow. What's happening? The post Guess which ASX 100 share is sinking 8% because of ...

1. Talk to yourself. There are times when you need expert advice. 2. “In style” are the clothes that still fit. 3. You don’t ...